The research strategy goals are to aggressively build on translational and clinical research activities; and engage basic scientific research programs to improve application of scientific discoveries to improve health of patients with diabetes and prevent diabetes mellitus.
The specific goals of the Mayo Clinic Diabetes Center are:
- Discover new metabolomic and genomic science related to diabetes mellitus, metabolism and obesity.
- Translate science by understanding its biologic expression in animals and humans.
- Apply newly discovered biology to the understanding of clinical diabetes in humans by testing the effects of intervention with pharmacologic and technologic therapies.
- Mayo Clinic is one of the world's largest private medical practices
- Clinical and translational science has been a fundamental activity at Mayo Clinic since it was established in the late 1800s
- Research at Mayo Clinic is not an end in itself, but a means of serving our primary mission — to give the best care to every patient, every day
- Mayo has significant research activity in the area of health care delivery for diabetes
- Mayo is involved in community-based diabetes research
- There are approximately 250 established laboratory-based research programs at Mayo.
- The state of Minnesota has invested in Biotechnology and Genomics Research since 2003 through the Minnesota Partnership for Biotechnology and Medical Genomics.
Mayo Clinic has long been recognized for conducting outstanding clinical research in diabetes. We are committed to establishing a robust and well-funded Diabetes Research Center that will attract additional investigators into the field and provide resources to more effectively prevent, treat and cure diabetes.
Mayo has significant research activity in the area of health care delivery for diabetes. We are involved in community-based diabetes research. BEACON is a grant to Mayo from the U.S. Department of Health and Human Services. It is conducted in an 11-county area in Southeast Minnesota for the purpose of determining whether better sharing of patients' health information through electronic medical records will improve treatment of diabetes and childhood asthma. Mayo is the only rural-area recipient to receive this funding.
The state of Minnesota also has invested in Biotechnology and Genomics Research through the Minnesota Partnership for Biotechnology and Medical Genomics. The partnership has expanded its involvement in diabetes research and launched "The Decade of Discovery," a 10-year program focused on preventing, optimally treating and ultimately curing diabetes.
Mayo has conducted Clinical Research Unit-based studies in diabetes for many years, facilitated by our NIH-funded Center for Translational Science Activities (CTSA) program with the goal of accelerating and transforming discoveries in the field of diabetes and related disorders.
Our research strategy is to translate basic science discovery into biologically relevant physiological observations, and subsequently apply those observations to prevent and control disease.
The Diabetes Research Center at Mayo Clinic provides tangible resources to promote collaborative interactions between basic, translational and clinical scientists.